Chart a Course to Better Protection

Bridge the gap that combination flea-tick-heartworm products leave behind.

Dog with red collar

Protect pets against more parasites for longer
with 2 trusted brands.

Get BRAVECTO Chews
Get SENTINEL SPECTRUM Chews

AVOID SHORTCUTS TO PROTECTION

Monthly combination flea-tick heartworm products can't deliver the duration of BRAVECTO Chews or the broad coverage of SENTINEL SPECTRUM Chews.
BRAVECTO Chews and SENTINEL SPECTRUM Chews coverage chart

Uncovering the compliance gap

Percentage of veterinarians recommending year-round protection
Number of months of protection purchased per year by pet owners

GREATER COMPLIANCE LEADS TO GREATER PROTECTION

Get more months of flea, tick, and heartworm protection with BRAVECTO Chews and SENTINEL SPECTRUM Chews.
Average number of months of protection purchsed per year. Additional months of protection compared with combination flea-tick-heartworm products chart.

BRAVECTO Chews provides 
extended duration for extended compliance

JUST 1 DOSE of BRAVECTO Chews goes further than the competition.1‡

Monthly products: 1 month. BRAVECTO Chews: 12 weeks.

‡BRAVECTO (fluralaner) Chews for Dogs kills fleas, prevents flea infestations, and kills ticks (black-legged tick, American dog tick, brown dog tick, and Asian longhorned tick) for 12 weeks. BRAVECTO Chews also kills lone star ticks for 8 weeks.

Dog with red collar

SENTINEL SPECTRUM Chews protects against whipworms and tapeworms2

73% of veterinarians recommend treating whipworms year round.
50% of veterinarians recommend treating tapeworms year round.

§Based on a study using PCR testing of perianal swabs from 877 dogs (589 pets, 288 shelter) from six states.

Greater compliance leads to great coverage

Learn more about BRAVECTO Chews
Learn more about SENTINEL SPECTRUM Chews

IMPORTANT SAFETY INFORMATION:
 
BRAVECTO (fluralaner) Chews for Dogs. The most commonly reported adverse reactions include vomiting, lethargy, diarrhea, anorexia and pruritus. In some cases, adverse events have been reported following use in breeding females. BRAVECTO Chews has not been shown to be effective for 12-weeks’ duration in puppies less than 6 months of age. BRAVECTO Chews is not effective against lone star ticks beyond 8 weeks of dosing. Fluralaner is a member of the isoxazoline class. This class has been associated with neurologic adverse reactions including tremors, ataxia, and seizures. Seizures have been reported in dogs receiving isoxazoline class drugs, even in dogs without a history of seizures. Use with caution in dogs with a history of seizures or neurologic disorders. For full product information refer to the product label.

SENTINEL SPECTRUM Chews (milbemycin oxime/lufenuron/praziquantel). Dogs should be tested for heartworm prior to use. Mild hypersensitivity reactions have been noted in some dogs carrying a high number of circulating microfilariae. Treatment with fewer than 6 monthly doses after the last exposure to mosquitoes may not provide complete heartworm prevention. For full product information refer to the product label.

References:

  1. BRAVECTO® Chews. Product label. Merck Animal Health; 2022.
  2. SENTINEL SPECTRUM® Chews. Product label. Merck Animal Health; 2023.
  3. Simparica TRIO®. Product label. Zoetis Inc.; 2020.
  4. NexGard® PLUS. Product label. Boehringer Ingelheim Animal Health USA Inc.; 2023.
  5. Credelio Quattro™. Product label. Elanco; 2024.
  6. Kynetec canine parasiticides brand health tracking—W4 Vets. August 8, 2023.
  7. The case for year-round flea and tick control. Companion Animal Parasite Council. Accessed September 24, 2024.
    https://capcvet.org/articles/the-case-for-year-round-flea-and-tick-control/
  8. Kynetec Heartworm and flea/tick category analysis—PetTrak™ MAT. June 2024.
  9. Trichuris vulpis. Companion Animal Parasite Council. Updated September 12, 2022. Accessed October 8, 2024. https://capcvet.org/guidelines/trichuris-vulpis/
  10. Little S, Braff J, Duncan K, et al. Diagnosis of canine intestinal parasites: Improved detection of Dipylidium caninum infection through coproantigen testing. Vet Parisitol. 2023;324:110073. doi:10.1016/j.vetpar.2023.110073
     
    All trademarks are the property of their respective owners.